Key Highlights

  • 7.35% is the indicated pre-market gain for Aimei Health Technology Co., Ltd (NASDAQ:AFJK) on November 17, 2026, lifting the price to USD 13.00 from a calculated prior close of USD 12.11, a USD 0.89 move.
  • 3.17 million shares outstanding imply a calculated market Capitalization of about USD 41.21 million at the indicated price, a thin float that can magnify price swings in either direction in pre-market trading.
  • 412,432 is the trailing Net Income in dollars, equal to USD 0.09 per share, and a price-to-earnings ratio of 133.56 was shown at the USD 12.25 close on October 15, 2026.
  • 8 is the day in July 2026 when the company announced termination of its Business combination agreement with United Hydrogen Group Inc., a deal first announced on June 20, 2024 at a USD 1.6 billion valuation.

What Moved Aimei Health Technology Co., Ltd (NASDAQ:AFJK) in Pre-Market Trading on November 17, 2026 (+USD 0.89, +7.35%)

The indicated pre-market price is USD 13.00, a pre-market move of +7.35%. The calculated prior close is USD 12.11 (USD 13.00 divided by 1.0735), and the calculated USD move is +USD 0.89. With 3.17 million shares outstanding, the calculated market capitalization is about USD 41.21 million. Pre-market Volume was not found. The shares closed at USD 12.25 on October 15, 2026, so the indicated price is a calculated 6.1% above that level.

The Rationale: No Catalyst Identified After the Terminated Merger for Aimei Health Technology Co., Ltd (NASDAQ:AFJK)

No catalyst for the November 17, 2026 move was identified in published coverage. The most notable recent event was the July 8, 2026 termination of the business combination agreement with United Hydrogen Group Inc., after which the shares fell sharply and trading halts for Volatility were reported around July 2026. Published market data also listed an estimated Earnings date of November 17, 2026, but no results were found. As general context, shell-type companies with small floats can move sharply on speculation about a new transaction, redemptions or a quarterly filing, and pre-market illiquidity widens swings.

Valuation, Liquidity and Risks for Aimei Health Technology Co., Ltd (NASDAQ:AFJK)

The calculated market capitalization of about USD 41.21 million is under USD 100 million, so small-cap and nano-cap warnings apply. Trailing net income of USD 412,432 and earnings of USD 0.09 per share imply the 133.56 multiple, which reflects a very small earnings base rather than an operating track record, as general context. Cash and Debt figures were not found. The company disclosed a Nasdaq notice on April 21, 2026 about a delayed Annual Report and another on May 20, 2026 about a delayed quarterly report. With the merger terminated, strategic direction is uncertain, and further filings may change the picture.

Where Things Stand

Aimei Health Technology Co., Ltd (NASDAQ:AFJK) is indicated up 7.35% in pre-market trading on November 17, 2026, at USD 13.00, a calculated gain of USD 0.89 from a prior close of USD 12.11. No catalyst was identified in published coverage. Background includes the July 8, 2026 termination of the United Hydrogen Group Inc. business combination agreement, Nasdaq notices dated April 21, 2026 and May 20, 2026 over delayed reports, and a share count of 3.17 million that supports a calculated market capitalization of about USD 41.21 million. Thin floats and pre-market illiquidity can reverse moves quickly, and this article is informational and is not Investment advice.